Project Details
| Status | Active |
|---|---|
| Effective start/end date | 17/12/25 → 16/12/27 |
Keywords
- clinical trial
- Angioedema
- Navenibart
Clinical Trial Phase
- Phase III (a & b)
- External Sponsor
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Navenibart in Participants with Hereditary Angioedema – ALPHA-ORBIT
- Zubrinich, Celia (Primary Chief Investigator (PCI))
Project: Research